يعرض 2,861 - 2,880 نتائج من 21,342 نتيجة بحث عن '(( significant ((clinical decrease) OR (linear decrease)) ) OR ( significant decrease decrease ))', وقت الاستعلام: 0.38s تنقيح النتائج
  1. 2861
  2. 2862
  3. 2863
  4. 2864
  5. 2865
  6. 2866
  7. 2867
  8. 2868
  9. 2869

    Baseline demographic characteristics. حسب Jung-Tae Kim (8997767)

    منشور في 2025
    الموضوعات:
  10. 2870
  11. 2871

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…"
  12. 2872

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…"
  13. 2873

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…"
  14. 2874

    Baseline Characteristics of Study Participants. حسب Swati M. Surkar (8399427)

    منشور في 2025
    "…The results demonstrate that DT training significantly improves and retains DT performance, likely due to a reduction in cognitive-motor interference. …"
  15. 2875

    Raw and processed data files. حسب Swati M. Surkar (8399427)

    منشور في 2025
    "…The results demonstrate that DT training significantly improves and retains DT performance, likely due to a reduction in cognitive-motor interference. …"
  16. 2876
  17. 2877
  18. 2878
  19. 2879

    Busulfan treatment induces orchitis. حسب Lingjun Zhao (21763122)

    منشور في 2025
    الموضوعات:
  20. 2880